Morgan Stanley analyst Michael Cyprys lowered the firm’s price target on Gemini (GEMI) to $13 from $29 and keeps an Equal Weight rating on the shares. Healthy transactional activity across brokers and exchanges in Q4 drives modest positive revision risk, notes the analyst in a preview. The analyst is raising Q4 EPS estimates by 5% on average, leaving the firm in-line with consensus, the analyst noted.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEMI:
- Gemini price target lowered to $13 from $16 at Citi
- Largest borrow rate increases among liquid names
- Winklevoss-Led Gemini Just Landed a Federal License to Legally Bring Prediction Markets into All 50 U.S. States
- Crypto Currents: Gemini receives U.S. license for prediction markets
- Crypto Exchange Gemini’s Stock (GEMI) Is Up 25% on News It’s Launching a Predictions Market